Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 25

    1.

    More about hearing.

    Rudnick SA.

    J Am Dent Assoc. 2003 Mar;134(3):274. No abstract available. PMID: 12699038 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Recombinant human erythropoietin and the treatment of anemia in patients with AIDS or advanced ARC not receiving ZDV.

    Henry DH, Jemsek JG, Levin AS, Levine JD, Levine RL, Abels RI, Nelson RA, Thompson D, Rudnick SA.

    J Acquir Immune Defic Syndr. 1992;5(8):847-8. No abstract available. PMID: 1517970 [PubMed - indexed for MEDLINE]Related articles

    3.

    OKT3E, an anti-CD3 antibody that does not elicit side effects or antiidiotype responses in chimpanzees.

    Rao PE, Olini G, Kille J, Muchmore E, Talle MA, Brake G, Rudnick SA.

    Transplantation. 1991 Oct;52(4):691-7.PMID: 1718067 [PubMed - indexed for MEDLINE]Related articles

    4.

    Erythropoietin: evolving clinical applications.

    Abels RI, Rudnick SA.

    Exp Hematol. 1991 Sep;19(8):842-50. Review. No abstract available. PMID: 1868899 [PubMed - indexed for MEDLINE]Related articles

    5.

    The role of recombinant human erythropoietin in the management of anemia associated with acquired immunodeficiency syndrome.

    Garnick MB, Abels R, Rudnick SA.

    Contrib Nephrol. 1991;88:282-92; discussion 293-4. No abstract available. PMID: 2040191 [PubMed - indexed for MEDLINE]Related articles

    6.

    In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma.

    Kirkwood JM, Ernstoff MS, Trautman T, Hebert G, Nishida Y, Davis CA, Balzer J, Reich S, Schindler J, Rudnick SA.

    J Clin Oncol. 1990 Jun;8(6):1070-82.PMID: 2112184 [PubMed - indexed for MEDLINE]Related articles

    7.

    Subcutaneous erythropoietin.

    Boughton KJ, Abels RI, Rudnick SA.

    Lancet. 1988 Sep 17;2(8612):684. No abstract available. PMID: 2901541 [PubMed - indexed for MEDLINE]Related articles

    8.

    Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma.

    Garnick MB, Reich SD, Maxwell B, Coval-Goldsmith S, Richie JP, Rudnick SA.

    J Urol. 1988 Feb;139(2):251-5.PMID: 3123714 [PubMed - indexed for MEDLINE]Related articles

    9.

    Reversible arrhythmias observed in patients treated with recombinant alpha 2 interferon.

    Martino S, Ratanatharathorn V, Karanes C, Samal BA, Sohn YH, Rudnick SA.

    J Cancer Res Clin Oncol. 1987;113(4):376-8.PMID: 3597523 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers.

    Kirkwood JM, Ernstoff MS, Davis CA, Reiss M, Ferraresi R, Rudnick SA.

    Ann Intern Med. 1985 Jul;103(1):32-6.PMID: 4003987 [PubMed - indexed for MEDLINE]Related articles

    11.

    A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy.

    Muss HB, Richards F 2nd, Homesley HD, Spurr CL, Rudnick SA, Stuart JJ, Plunkett S, Welander C, Caponera M, White DR, et al.

    Am J Clin Oncol. 1985 Apr;8(2):97-107.PMID: 3834792 [PubMed - indexed for MEDLINE]Related articles

    12.

    The radiologic diagnosis of pancreatic cancer. The effect of new imaging techniques.

    Yankaskas BC, Staab EV, Rudnick SA, Fletcher RH.

    Invest Radiol. 1985 Jan-Feb;20(1):73-8.PMID: 3884547 [PubMed - indexed for MEDLINE]Related articles

    13.

    A phase II study of recombinant alpha interferon in patients with recurrent or metastatic breast cancer.

    Muss HB, Kempf RA, Martino S, Rudnick SA, Greiner J, Cooper MR, Decker D, Grunberg SM, Jackson DV, Richards F 2nd, et al.

    J Clin Oncol. 1984 Sep;2(9):1012-6.PMID: 6470752 [PubMed - indexed for MEDLINE]Related articles

    14.

    The identification of a murder victim using a comparison of the postmortem and antemortem records.

    Rudnick SA.

    J Forensic Sci. 1984 Jan;29(1):349-54.PMID: 6699604 [PubMed - indexed for MEDLINE]Related articles

    15.

    Use of cost-effectiveness analysis in planning cancer chemoprophylaxis trials.

    Guess HA, Rudnick SA.

    Control Clin Trials. 1983 Jun;4(2):89-100.PMID: 6411430 [PubMed - indexed for MEDLINE]Related articles

    16.

    High-dose methotrexate in small cell lung cancer. Lack of efficacy in preventing CNS relapse.

    Neijstrom ES, Capizzi RL, Rudnick SA, Kirsch M, Delaney D, Kahn L, Lipper S, Carney C.

    Cancer. 1983 Mar 15;51(6):1056-61.PMID: 6295620 [PubMed - indexed for MEDLINE]Related articles

    17.

    Use of the flexible sigmoidoscope in women with previous pelvic irradiation.

    Sandler RS, Varma V, Herbst CA Jr, Montana GS, Rudnick SA, Fowler WC Jr.

    Gastrointest Endosc. 1982 Nov;28(4):237-9.PMID: 7173574 [PubMed - indexed for MEDLINE]Related articles

    18.

    Methotrexate cytotoxicity for L5178Y/Asn- lymphoblasts: relationship of dose and duration of exposure to tumor cell viability.

    Keefe DA, Capizzi RL, Rudnick SA.

    Cancer Res. 1982 May;42(5):1641-5.PMID: 7066887 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Randomized phase II comparison of methotrexate with or without L-asparaginase in non-small cell cancer of the lung.

    Rudnick SA, Neijstrom E, Capizzi RL, Delaney D, Kirsch M.

    Cancer Treat Rep. 1982 Mar;66(3):541-4. No abstract available. PMID: 7060040 [PubMed - indexed for MEDLINE]Related articles

    20.

    Childhood Burkitt-type lymphoma at the North Carolina Memorial Hospital.

    Gaddy D, Rudnick SA, McMillan C, Lipper S.

    N C Med J. 1981 Jan;42(1):29-34. No abstract available. PMID: 6937735 [PubMed - indexed for MEDLINE]Related articles

    21.

    Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.

    Aronin PA, Mahaley MS Jr, Rudnick SA, Dudka L, Donohue JF, Selker RG, Moore P.

    N Engl J Med. 1980 Jul 24;303(4):183-8.PMID: 7383088 [PubMed - indexed for MEDLINE]Related articles

    22.

    Breast carcinoma metastatic to meningioma.

    Nunnery E Jr, Kahn LB, Rudnick SA.

    Arch Pathol Lab Med. 1980 Jul;104(7):392-3. No abstract available. PMID: 6893129 [PubMed - indexed for MEDLINE]Related articles

    23.

    An analysis of the reporting of results in lung cancer drug trials.

    Rudnick SA, Feinstein AR.

    J Natl Cancer Inst. 1980 Jun;64(6):1337-43. No abstract available. PMID: 6990073 [PubMed - indexed for MEDLINE]Related articles

    24.

    Operational criteria for adverse drug reactions in evaluating suspected toxicity of a popular scabicide.

    Kramer MS, Hutchinson TA, Rudnick SA, Leventhal JM, Feinstein AR.

    Clin Pharmacol Ther. 1980 Feb;27(2):149-55.PMID: 6153304 [PubMed - indexed for MEDLINE]Related articles

    25.

    High dose cytosine arabinoside (HDARAC) in refractory acute leukemia.

    Rudnick SA, Cadman EC, Capizzi RL, Skeel RT, Bertino JR, McIntosh S.

    Cancer. 1979 Oct;44(4):1189-93.PMID: 498009 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...